Medical
Curaleaf’s October Effort Brings Communities into Breast Cancer Research Funding
This October, Curaleaf Holdings, Inc. (TSX: CURA OTCQX: CURLF) is marking the sixth anniversary of its national donation program for Breast Cancer Action Month, reaffirming...
Nightingale Health’s New Tool Detects Cardiovascular Risk from Lipoprotein (a) with Cost Efficiency
Nightingale Health (NASDAQ Helsinki: HEALTH, OTCQX: NGHLF) has introduced a novel risk detection tool aimed at identifying individuals likely to have dangerously high levels of...
Microbix Client Labquality Launches New Program to Improve HPV-Related Cancer Diagnostics
Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF), a Canadian company specializing in life sciences products, and Labquality Oy, a Finnish clinical laboratory quality assessment provider,...
Vireo Growth Inc Launches Adult-Use Cannabis Sales in Minnesota with Eight Dispensaries Now Serving New Market
Vireo Growth Inc (CSE: VREO; OTCQX: VREOF) officially began selling adult-use cannabis today at its downtown Minneapolis Green Goods® dispensary. This milestone marks a significant...
Perimeter Medical Imaging AI Steps Up Collaboration in Breast Surgery Field
Perimeter Medical Imaging AI, Inc. (TSX-V: PINK, OTCQX: PYNKF) has joined the Industry Relations Council of the American Society of Breast Surgeons, a move that...
New Dispensaries Signal Continued Growth for U.S. Cannabis Market
The U.S. cannabis market is continuing its growth trajectory as leading companies expand their retail footprints, bringing legal marijuana products closer to more consumers across...
Orexo Unlocks New Possibilities with Intranasal Delivery for GLP-1 Medications
The world of drug delivery is entering a new phase, and Orexo AB (publ.) (Nasdaq Stockholm: ORX, OTCQX: ORXOY) is helping lead the charge with...
PetVivo Holdings Expands Access to Innovative Animal Joint Care
PetVivo Holdings, Inc. (OTCQX: PETV), a biomedical device company known for its veterinary medical innovations, has entered a distribution agreement with Nupsala Limited to introduce...
Viking Therapeutics Faces Investor Setback as Obesity Pill Trial Highlights Challenges
Viking Therapeutics (NASDAQ: VKTX) saw its stock plunge sharply following the release of Phase 2 trial results for its obesity treatment, signaling growing concerns among...
Novo Nordisk Halves Ozempic Price for Americans Paying Out of Pocket
Novo Nordisk (Nasdaq: NVO) made headlines today with a move that could mark a turning point for self-paying Americans managing diabetes and obesity. The Danish...
